Inactive Instrument
Auspex Pharmaceuticals Inc Stock
Stocks
US05211J1025
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 15-04-22 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
| 15-04-22 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Brendan O'Grady
CEO | Chief Executive Officer | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sep Sarshar
BRD | Director/Board Member | 59 | 2009-08-31 |
Rod Ferguson
BRD | Director/Board Member | 69 | 2012-12-31 |
Alex Zisson
BRD | Director/Board Member | 56 | 2013-10-16 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.43% | -4.26% | +52.09% | +85.69% | 55.57B | ||
| -0.24% | +1.04% | +55.76% | +54.21% | 54.26B | ||
| -1.82% | -2.89% | +3.61% | +405.88% | 23.54B | ||
| -0.54% | -0.17% | -17.60% | -15.43% | 23.35B | ||
| +0.31% | -0.92% | +35.51% | -3.92% | 20.32B | ||
| +3.16% | +0.79% | +37.98% | -31.36% | 17.36B | ||
| +0.58% | -0.48% | +38.67% | +551.63% | 15.59B | ||
| +0.43% | -10.61% | +175.63% | +299.61% | 14.96B | ||
| -2.03% | -1.03% | +23.63% | +179.23% | 14.11B | ||
| Average | -0.06% | -0.71% | +45.03% | +169.50% | 26.56B | |
| Weighted average by Cap. | -0.19% | -0.44% | +44.08% | +133.38% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















